InflaRx’s First-in-class C5a/C5aR Signaling Pathway Strategy - Data Intelligence

InflaRx’s First-in-class C5a/C5aR Signaling Pathway Strategy - Data Intelligence

Inflammatory diseases involve excessive or ongoing inflammation that damages tissues and affects many different human systems, including digestion, immunity, circulation, breathing, and the nervous system. The demand for anti-inflammatory treatments is growing quickly and is tipped to top a quarter of a trillion dollars within the decade as cases increase and new approaches to address inflammation emerge. This week, I had the chance to talk to N…

Taking the fight to inflammatory disease: InflaRx’s first-in-class C5a/C5aR signaling pathway strategy - Beyond Biotech - the podcast from Labiotech

Inflammatory diseases involve excessive or ongoing inflammation that damages tissues and affects many different human systems, including digestion, immunity, circulation, breathing, and the nervous system. The demand for anti-inflammatory treatments is growing quickly and is tipped to top a quart...